当前位置:首页 - 行情中心 - 我武生物(300357) - 财务分析 - 现金流量表

我武生物

(300357)

  

流通市值:116.72亿  总市值:126.29亿
流通股本:4.84亿   总股本:5.24亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金228,767,671.71,101,022,588.47850,177,687.74516,650,905.38
  收到其他与经营活动有关的现金1,640,423.6233,074,833.8620,446,041.7412,510,748.27
  经营活动现金流入小计230,408,095.321,134,097,422.33870,623,729.48529,161,653.65
  购买商品、接受劳务支付的现金3,092,636.1828,296,506.9822,371,170.5116,271,293.87
  支付给职工以及为职工支付的现金78,362,454.12293,250,722.49214,559,678.61142,754,196.26
  支付的各项税费30,501,111.67123,177,647.6357,379,994.6548,447,199.23
  支付其他与经营活动有关的现金63,402,753.79266,176,798.62289,421,808.2121,173,112.19
  经营活动现金流出小计175,358,955.76710,901,675.72583,732,651.97328,645,801.55
  经营活动产生的现金流量净额55,049,139.56423,195,746.61286,891,077.51200,515,852.1
二、投资活动产生的现金流量:
  收回投资收到的现金303,197,865.381,101,588,389741,491,647.25451,567,200
  取得投资收益收到的现金1,291,608.793,496,824.763,205,479.621,465,742.81
  处置固定资产、无形资产和其他长期资产收回的现金净额211.71---
  收到的其他与投资活动有关的现金100,000---
  投资活动现金流入小计304,589,685.881,105,085,213.76744,697,126.87453,032,942.81
  购建固定资产、无形资产和其他长期资产支付的现金19,366,907.59119,347,815.69110,988,794.9688,217,827.02
  投资支付的现金238,672,0001,224,670,000752,760,000489,760,000
  支付其他与投资活动有关的现金2,451,118.2532,946,107.4531,204,529.999,155,282.02
  投资活动现金流出小计260,490,025.841,376,963,923.14894,953,324.95587,133,109.04
  投资活动产生的现金流量净额44,099,660.04-271,878,709.38-150,256,198.08-134,100,166.23
三、筹资活动产生的现金流量:
  取得借款收到的现金5,000,00020,000,00020,000,00015,000,000
  筹资活动现金流入小计5,000,00020,000,00020,000,00015,000,000
  偿还债务支付的现金5,000,00027,628,987.8527,628,987.8522,577,392.71
  分配股利、利润或偿付利息支付的现金52,393,601.39115,298,368.9115,179,627.1652,430,858.34
  支付其他与筹资活动有关的现金1,538,824.076,181,817.095,009,063.523,474,035.3
  筹资活动现金流出小计58,932,425.46149,109,173.84147,817,678.5378,482,286.35
  筹资活动产生的现金流量净额-53,932,425.46-129,109,173.84-127,817,678.53-63,482,286.35
四、汇率变动对现金及现金等价物的影响-6,424.71-7,171.42-4,046.21-4,641.7
五、现金及现金等价物净增加额45,209,949.4322,200,691.978,813,154.692,928,757.82
  加:期初现金及现金等价物余额120,062,978.7897,862,286.8197,862,286.8197,862,286.81
  期末现金及现金等价物余额165,272,928.21120,062,978.78106,675,441.5100,791,044.63
补充资料:
  净利润-368,089,245.89-170,429,226.33
  资产减值准备-5,611,447.2-2,207,917.71
  固定资产和投资性房地产折旧-35,408,140.69-16,183,925.54
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-35,408,140.69-16,183,925.54
  无形资产摊销-14,573,789.77-6,725,077.34
  长期待摊费用摊销-1,704,146.99-1,208,203.77
  处置固定资产、无形资产和其他长期资产的损失--630,073.33--630,073.33
  固定资产报废损失-344,118.81-320,072.27
  公允价值变动损失--3,425,972.25--1,328,169.78
  财务费用-793,087.05-406,344.87
  投资损失--2,721,381.62--16,143.8
  递延所得税--114,111.15--480,927.78
  其中:递延所得税资产减少-24,690.82--452,417.26
    递延所得税负债增加--138,801.97--28,510.52
  存货的减少-2,975,746.21-1,380,977.75
  经营性应收项目的减少-9,025,610.68-10,543,053.48
  经营性应付项目的增加--14,206,156.54--9,356,634.69
  现金的期末余额-120,062,978.78-100,791,044.63
  减:现金的期初余额-97,862,286.81-97,862,286.81
  现金及现金等价物的净增加额-22,200,691.97-2,928,757.82
公告日期2026-04-242026-04-242025-10-242025-08-22
审计意见(境内)标准无保留意见
TOP↑